Cognitive Training with Ketamine for Depression

Cognitive Training as an Adjunct to Ketamine in Real-world Clinics

Recruiting N/A Interventional Study
Depression
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
600 (estimated)
Sponsor
University of Pittsburgh · Other
Who this trial is looking for

This trial is looking for adults aged 18 to 80 who are being treated with ketamine for depression. Participants will receive additional computer-based cognitive training to see if it helps improve their treatment outcomes.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am between 18 and 80 years old.
  • I have a depression score of 20 or higher.
  • I have been diagnosed with Major Depressive Disorder, Bipolar Disorder, or another depressive disorder.
  • I have not responded to at least one previous treatment for depression.
  • I am scheduled to start a ketamine treatment soon.
  • I agree to keep my psychiatric medications stable during the trial.
  • I can understand and agree to all study procedures.
  • I can provide an emergency contact.

You may not be able to join if

  • I currently have acute psychosis, mania, or dementia.
  • I am at risk of suicide and intend to act on it.
  • I have signs of significant cognitive decline or dementia.
  • I am currently pregnant.
  • I cannot read at least at a 5th-grade level in English.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
In a sample of patients already receiving ketamine (or esketamine) treatment as part of their clinical care, this project seeks to test whether we can enhance and/or extend (es)ketamine's rapid effects by introducing helpful information delivered by a computer-based cognitive training protocol. This work could ultimately lead to the ability to treat depression more efficiently and with broader dis…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. be between the ages of 18 and 80 years 2. score ≥20 on the Montgomery-Asberg Depression Rating Scale (MADRS) 3. per SCID-5-RV interview, meet DSM-5 diagnostic criteria for at least one of the following: Major Depressive Disorder, Bipolar Disorder (I or II), Persistent Depress…
Contacts

Rebecca B Price, PhD

412-383-2150

ketclinics@pitt.edu

CONTACT

Iya Cooper, B.S.

240-242-7318

ketclinics@pitt.edu

CONTACT